Physician

General Surgery

Firoozeh F. Sahebi is an expert in the field of General Surgery. She over the years received 1 awards: "Meaningful Use Stage 1 Certification". Firoozeh Sahebi is a published doctor as well. She has 30 publications published. The latest was: Mucormycosis of the vulva following bone marrow transplantation.

Publications

---

• Graft-versus-host disease and Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.
• Second primary malignancies after autologous hematopoietic cell transplantation for multiple Myeloma.
• Late relapses following reduced intensity allogeneic transplantation in patients with multiple Myeloma: a long-term follow-up study.
• Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple ...
• Human herpesvirus 8 (KSHV) contamination of peripheral blood and autoGraft products from multiple myeloma patients.
• Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple Myeloma.
• Mucormycosis of the vulva following bone marrow transplantation.
• Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
• Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple Myeloma.
• Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients ...
• A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory Acute myelogenous leukemia: impact of cytogenetic characteris...
• Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.
• Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple Myeloma.
• Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on ch...
• Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple Myeloma.
• Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
• Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple Myeloma (BMT CT...
• Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple Myeloma.
• Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell Lymphomas.
• Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with Acute myeloid leukemia.
• Improved outcomes using tacrolimus/sirolimus for Graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell ...
• Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative alloGrafting.
• Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell Lymphoma: a multicentre experience.
• Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis.
• A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplant...
• Efficacy of mycophenolate mofetil in the treatment of Chronic graft-versus-host disease.
• Acute renal failure after nonmyeloablative hematopoietic cell transplantation.
• AlloGrafting with nonmyeloablative conditioning following cytoreductive autoGrafts for the treatment of patients with multiple myeloma.
• Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant Diseases.

Procedures Preformed

---

• HPC Transplantation (Stem Cell Transplant)

Conditions Treated

---

• Acute Leukemia
• Anemia
• Chronic Myeloid Leukemia (CML)
• Deep Vein Thrombosis (DVT)
• View All

Doctors Specialties

---

• Transplant Surgery
• General Surgery

Accepted Insurances

---

Awards

---

• Meaningful Use Stage 1 Certification

Education

---

• UCLA Medical Center
• Nassau University Medical Center
• Shahid Beheshti University of Medical Sciences

Hospital

---

• City of Hope's Helford Clinical Research Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Neil M. Kogut, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Leonardo T. Farol III, MD This Doctor is OpenDoctor Recommended.
	Dr. Ji-Lian Cai, MD This Doctor is OpenDoctor Recommended.
	Dr. Subarna Biswas, MD This Doctor is OpenDoctor Recommended.
	Dr. William H. Clark, MD
	Dr. Henrik Petrowsky, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Hasan Yersiz, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Justin P. Wagner, MD
	Dr. Thai M. Cao, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog